Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Renal Cell × Radiofrequency Ablation × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 5 Thyroid Nodule 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 NSCLC 1 Lung Neoplasms 1 Leiomyoma 1 Gastrointestinal Stromal Tumors 1 Gastritis, Atrophic 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Cancer Metastatic 1 Bile Duct Neoplasms 1 Adrenocortical Adenoma 1 Adenocarcinoma 1

Interventions

Sunitinib 13 Sorafenib 13 cabozantinib 7 Blood Specimen Collection 6 pazopanib 5 Axitinib 5 temsirolimus 4 avelumab 3 Watchful Waiting 3 Specimen Handling 3 Immunohistochemistry 3 Gene Expression Profiling 3 Everolimus 3 Bevacizumab 3 pembrolizumab 2 Urine Specimen Collection 2 Nephrectomy 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Immunotherapy 2 Flow Cytometry 2 Data Collection 2 trastuzumab deruxtecan 1 lenvatinib 1 fluoroazomycin arabinoside 1 enfortumab vedotin 1 darolutamide 1 atezolizumab 1 aldesleukin 1 Tyrosine Kinase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07465458 2026-03-16

RASROP-003

Humanitas Hospital, Italy

Not yet recruiting

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡